Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Phospholamban (PLN) (pSer16), (pSer17) Peptide

PLN Reactivity: Human, Rat, Cow, Dog, Mouse, Pig, Rabbit Host: Synthetic BP
Catalog No. ABIN2711843

Quick Overview for Phospholamban (PLN) (pSer16), (pSer17) Peptide (ABIN2711843)

Target

Phospholamban (PLN)

Origin

Human, Rat, Cow, Dog, Mouse, Pig, Rabbit

Source

  • 2
Synthetic

Application

Blocking Peptide (BP)
  • Protein Region

    pSer16, pSer17

    Characteristics

    The peptide is used to block Anti-Phospholamban (pS16/T17) Antibody reactivity.
  • Application Notes

    Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Storage

    -20 °C

    Storage Comment

    Shipped at 4°C. Store at -20°C for one year.

    Expiry Date

    12 months
  • Jin, Nesbitt, Yang, Chen, Horowitz, Jones, Vandergaast, Carey, Reiter, Russell, Kyratsous, Hooper, Hamilton, Ferreira, Deng, Straus, Baras, Hillyer, Luchsinger: "Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening"." in: PloS one, Vol. 16, Issue 4, pp. e0250319, (2021) (PubMed).

  • Target

    Phospholamban (PLN)

    Background

    PLB, Cardiac phospholamban, PLB

    Gene ID

    5350, 18821, 64672

    UniProt

    P26678, P61014, P61016
You are here:
Chat with us!